Drug therapy is now the preferred method of treatment for spasticity, and several effective agents have been developed. The safety and efficacy of these drugs has been established in short-term studies. Overall, due to its low incidence of sedation and serious side effects, baclofen appears to be the drug of choice in the treatment of spinal cord-related spasticity. It is, however, not without its side effects due to both its administration and abrupt withdrawal. This case illustrates some significant problems associated with the abrupt withdrawal of long-term baclofen therapy in a patient with multiple sclerosis.
MCDOWELLF.H.Treatment of spasticity. Drugs1981; 22: 401–8.
2.
DUNCANG.W., SHAHVARIB.T., VOUNGR.R.An evaluation of baclofen treatment for certain symptoms in patients with spinal cord lesions: a double-blind cross-over study. Neurology1976; 26: 441–6.
3.
VOUNGR.R., DELWAIDEP.J.Spasticity (Part II). N Engl J Med1981; 304: 96–9.
4.
TERRENCEC.F., FROMMG.H.Complications of baclofen withdrawal. Arch Neurol1984; 38: 588–9.
5.
MERRITTJ.L.Management of spasticity in spinal cord injury. Mayo Clin Proc1981; 56: 614–22.
6.
KIRUBAKARANV., MAYFIELDD., RENGACHARYS.Dyskinesia and psychosis in a patient following baclofen withdrawal. Am J Psychiatry1984; 141: 692–3.
7.
HYSERC.L., DRAKEM.E.Status epilepticus after baclofen withdrawal. J Natl Med Assoc1984; 76: 533–8.
